Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | April 7, 2010 |
| Target | Achaogen |
| Sector | Life Science |
| Investor(s) | Alta Partners |
| Deal Type | Venture |
FILTER BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| Deal Context for Investor | # |
|---|---|
| Overall | 47 of 59 |
| Sector: Life Science | 40 of 50 |
| Type: Venture | 39 of 48 |
| State: California | 26 of 31 |
| Country: United States | 39 of 50 |
| Year: 2010 | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-15 |
Anesiva
South San Francisco, California, United States Anesiva, Inc. is a pharmaceutical company that licenses, develops, and commercializes drugs for pain. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-29 |
ATS Medical
Minneapolis, Minnesota, United States ATS Medical, Inc., engages in the development, manufacture and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve and heart valve repair products. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, and it is developing minimally invasive and off-pump aortic valve concepts. |
Sell | $370M |
